# Paul Reilly

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-reilly/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,747 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 51 |
| i10-index | 99 |
| Last Known Institution | Centro de Investigación del Cáncer |
| OpenAlex ID | https://openalex.org/A5110573364 |
| Works | 176 |

## Researcher papers

- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Idarucizumab for Dabigatran Reversal — Full Cohort Analysis](https://scholariq.org/papers/idarucizumab-for-dabigatran-reversal-full-cohort-analysis/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Heparin-Induced Thrombocytopenia and Thrombosis](https://scholariq.org/topics/heparin-induced-thrombocytopenia-and-thrombosis/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)

## Researcher university

- [Centro de Investigación del Cáncer](https://scholariq.org/institutions/centro-de-investigacion-del-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
